Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: A European case-control study
Aminkeng Zawuo Leke(University of Ulster), David Tucker(UNSW Sydney), Anna Latos Bieleńska(Medicina), Helen Dolk(University of Ulster), Clara Cavero‐Carbonell(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana), Ester Garne(University of Southern Denmark), Kari Klungsøyr(Norwegian Institute of Public Health), Vera Nelen(Provincial Institute for Hygiene), Anna Pierini(Istituto di Fisiologia Clinica), Karen Casson(University of Ulster), Jorieke E. H. Bergman(University Medical Center Groningen), Marie-Claude Addor(Centre Hospitalier Universitaire Vaudois), Mary O’Mahony(Health Service Executive), Anna Materna‐Kiryluk(Medicina), Ingeborg Barišić(University of Zagreb), Anke Rissman(Otto-von-Guericke-Universität Magdeburg), Amanda J. Neville(University of Ferrara), Maria Loane(University of Ulster)
Cited by 18
Related Papers
UK health performance: findings of the Global Burden of Disease Study 2010
|The Lancet|2013|557
Epidemiology of congenital diaphragmatic hernia in Europe: a register-based study
|Archives of Disease in Childhood Fetal & Neonatal|2014|311
Long term trends in prevalence of neural tube defects in Europe: population based study
|BMJ|2015|247
Associated anomalies in multi‐malformed infants with cleft lip and palate: An epidemiologic study of nearly 6 million births in 23 EUROCAT registries
|American Journal of Medical Genetics Part A|2007|243
Estimating Global Burden of Disease due to congenital anomaly: an analysis of European data
|Archives of Disease in Childhood Fetal & Neonatal|2017|224